Table of contents
Equity Research Initial Coverage: RELX plc – The AI-Driven Cash Machine in Focus
With this study, we initiate coverage of RELX plc (ISIN: GB00B2B0DG97 / Ticker: REL LN, REN NA, RELX US). Over the past two decades, the company has executed a consistent strategic portfolio transformation from a traditional print and media publisher into a global leader in information-based analytics, decision tools, and proprietary data platforms. With a market capitalisation of around £74 billion, RELX is among Europe’s most valuable and profitable data and technology groups. The combination of software solutions deeply embedded in B2B workflows, advanced artificial intelligence (AI) algorithms, and irreplaceable datasets gives the company an exceptional quality profile with highly predictable, highly profitable, and recession-resistant cash flows.
Business Model
Executive Summary & Investment Thesis
The investment story of RELX is built on the reliable transformation of a classic information provider into a global, AI-driven data and analytics platform. The company acts as an indispensable infrastructure provider for law firms, researchers, financial institutions, insurers, and corporate clients worldwide. RELX’s operating strength rests on four key pillars which, together, deliver superior return on equity and steady value creation for shareholders:
Structural acceleration of organic revenue growth: The ongoing shift of the product portfolio from static databases to predictive analytics and generative AI decision tools is sustainably driving organic revenue growth. For fiscal year 2025, RELX reported underlying revenue growth of +7% to £9,590 million. This growth trajectory is driven in particular by steadily rising demand for complex risk management and legal analytics solutions.
Continuous margin expansion through operating leverage: The business model is characterised by exemplary cost discipline. Management pursues the strict goal of consistently keeping underlying cost growth below underlying revenue growth. This led in fiscal year 2025 to a further increase in the adjusted operating margin (Adjusted Operating Margin) by 90 basis points to 34.8% (from 33.9% in 2024). Adjusted operating profit increased on an underlying basis by +9% to £3,342 million.
Outstanding cash generation and disciplined capital allocation: With operating cash flow conversion of 99% and free cash flow of £2,313 million, RELX generates substantial liquidity. The company uses this strength for a shareholder policy that combines steady dividend increases with extensive share buybacks. For 2025, the dividend was raised by +7% to 67.5p. In addition to share buybacks of £1.5 billion in 2025, management announced an increase of the buyback programme to £2.25 billion for 2026.
Artificial intelligence as a moat amplifier: While the market at times feared that generative AI models could commoditise the business of traditional data providers, RELX’s real-world experience shows the opposite. The company uses its protected, verified data assets as a closed knowledge base for its own AI assistants such as Lexis+ AI, Protégé or ClinicalKey AI. This eliminates the problem of AI hallucinations in critical use cases, significantly increases customer value, and sustainably raises users’ willingness to pay.
Company profile & business model
RELX structures its business activities into four global segments: Risk; Scientific, Technical & Medical (STM); Legal; and Exhibitions.
Detailed segment analysis
| Segment | Umsatz 2025 (Mio. GBP) | EBIT bereinigt 2025 (Mio. GBP) | Operative Marge 2025 | Unterliegendes Umsatzwachstum | Unterliegendes EBIT-Wachstum | Kernmarken & Produktplattformen |
|---|---|---|---|---|---|---|
| Risk | 3.485 | 1.305 | 37,4 % | +8 % | +10 % | LexisNexis Risk Solutions, ICIS, Cirium, ThreatMetrix |
| Scientific, Technical & Medical (STM) | 2.714 | 1.035 | 38,1 % | +5 % | +7 % | Elsevier, ScienceDirect, Scopus, ClinicalKey |
| Legal | 1.806 | 415 | 23,0 % | +9 % | +12 % | LexisNexis, Lexis+ AI, Protégé, CourtLink |
| Exhibitions (RX) | 1.186 | 410 | 34,6 % | +8 % | +9 % | RX (Reed Exhibitions) |
| Gesamt Konzern | 9.590 | 3.342 | 34,8 % | +7 % | +9 % | RELX Group |
| Segment | Revenue 2025 (GBP million) | Adjusted EBIT 2025 (GBP million) | Operating Margin 2025 | Underlying Revenue Growth | Underlying EBIT Growth | Core Brands & Product Platforms |
|---|---|---|---|---|---|---|
| Risk | 3,485 | 1,305 | 37.4% | +8% | +10% | LexisNexis Risk Solutions, ICIS, Cirium, ThreatMetrix |
| Scientific, Technical & Medical (STM) | 2,714 | 1,035 | 38.1% | +5% | +7% | Elsevier, ScienceDirect, Scopus, ClinicalKey |
| Legal | 1,806 | 415 | 23.0% | +9% | +12% | LexisNexis, Lexis+ AI, Protégé, CourtLink |
| Exhibitions (RX) | 1,186 | 410 | 34.6% | +8% | +9% | RX (Reed Exhibitions) |
| Consolidated Total | 9,590 | 3,342 | 34.8% | +7% | +9% | RELX Group |
In the Risk segment, the group’s largest and most profitable division, RELX supports corporate clients and public authorities with fraud prevention, identity verification, compliance with anti-money laundering requirements (Financial Crime Compliance), and actuarial risk analytics. Within the LexisNexis Digital Identity Network, RELX analyses more than 345 million digital transactions per day and over 121 billion per year. The division also supports US P&C insurers in more than 231 million insurance decisions annually.
The Scientific, Technical & Medical (STM) segment is dominated by the heritage brand Elsevier. RELX publishes a significant share of global primary research and provides scientific databases. Platforms such as ScienceDirect (literature database) and Scopus (citation and analytics database), as well as ClinicalKey in the medical field, are global standards at research universities, academic institutions, and hospitals.
The Legal segment provides legal primary and secondary sources, case law, statutes, and AI-powered analytics tools for law firms, corporate legal departments, and public institutions via the LexisNexis platform. The successful launch of the generative AI platforms Lexis+ AI and the next-generation Protégé has accelerated underlying revenue growth in this area to an impressive 9%.
The Exhibitions segment offers B2B trade shows worldwide under the RX brand. The business has fully recovered after the pandemic and is increasingly benefiting from data-driven networking opportunities that increase ROI for exhibitors and visitors.
Product offering, monetisation mechanism and market structure
RELX sells its products and services exclusively in the B2B segment. Customers include 91% of Fortune 100 companies, 85% of Fortune 500 companies, 9 of the world’s 10 largest banks, 23 of the 25 largest global insurers, and 99% of all US auto and property insurers. The world’s leading law firms, government agencies, and thousands of academic university libraries are also part of its established customer base.
Monetisation is based on two highly efficient models: The majority of revenues (54% of total revenue) comes from recurring subscription contracts, typically with terms of one to three years and renewal rates above 90%. Transaction-based and volume-based fees account for 39% of revenue, primarily in the Risk segment, where customers pay per search, credit check, or fraud check. Exhibition fees at trade shows contribute 12%, while the legacy print business now accounts for only around 4% of group revenue. Electronic formats represent 84% of total group revenues.
The business model is transparent and easy to understand: RELX collects vast amounts of unstructured raw data—such as court rulings, scientific manuscripts, crime statistics, or financial transactions—enriches them with its own algorithms, taxonomies, and AI models, and embeds them as essential software tools directly into customers’ workflows.
RELX operates in the professional information services, data analytics, LegalTech and risk analytics industry. The group’s best-known brands include LexisNexis, Elsevier, ScienceDirect, Scopus, ClinicalKey, ThreatMetrix, ICIS, Cirium and RX.
Geographically, the company is active in more than 180 countries and territories and maintains offices in around 40 countries. The operational focus is North America, contributing 58% of total revenues. Europe accounts for around 20–25%, while the remaining revenues are generated in the fast-growing markets of Asia and Latin America. The group holds pronounced market leadership positions in the US and the UK.
RELX PLC is headquartered in London, United Kingdom (1-3 Strand, London WC2N 5JR). The ordinary shares are traded on the London Stock Exchange (Ticker: REL) and Euronext Amsterdam (Ticker: REN). In the US, sponsored ADRs are listed on the New York Stock Exchange (Ticker: RELX). The company is a constituent of major equity indices, including the FTSE 100, the AEX, the STOXX Europe 600 and the MSCI World Index.
Historical Development, Milestones, and Anecdotes
RELX’s origins date back to the late 19th century. The company in its current form was created in 1993 through the merger of two long-established publishing houses: the British Reed International and the Dutch Elsevier NV.
Albert E. Reed founded a paper mill in Kent, England, in 1894, which evolved over the 20th century into a leading media and publishing conglomerate. Elsewhere, Elsevier NV was founded in 1880 by Jacobus George Robbers in Amsterdam. Robbers chose the name Elsevier in reference to the famous Dutch printing family Elzevir, which published works by thinkers such as René Descartes, Galileo Galilei and Erasmus of Rotterdam in the 16th and 17th centuries. The historic company logo— a hermit under an elm tree entwined with grapevines, bearing the Latin motto “Non Solus” (“Not alone”)—still symbolises the interplay between scholar and publisher and adorns all Elsevier scientific publications to this day.
A major strategic turning point came in 2018: the historically grown, highly complex dual holding structure with two separate parent companies in London and Amsterdam was fully dissolved and consolidated under a single group parent, RELX PLC.
Over the past two decades, management has executed a radical transformation: print products, consumer magazines, regional newspapers, and paper manufacturing divisions were systematically divested. Instead, RELX reinvested the released capital into building massive databases, cybersecurity solutions (such as the landmark acquisition of ThreatMetrix), and advanced analytics algorithms. RELX has thus successfully evolved from a 19th-century paper manufacturer into a global AI infrastructure leader of the 21st century.
Competitive Advantage (Economic Moat)
RELX has a broad and exceptionally deep economic moat (Wide Economic Moat) that sustainably protects the business from risks and competitive pressure. This moat is reflected in a persistently high Return on Invested Capital (ROIC), which stood at an excellent 15.4% in fiscal year 2025.
Structural moat factors
RELX’s sustainable competitive advantage rests on four fundamental pillars that make barriers to entry for potential challengers almost insurmountable:
High switching costs (Switching Costs) through deep workflow integration: RELX’s products are not standalone software tools, but an essential part of customers’ daily workflows. If a major bank has connected its AML screening and anti-fraud systems via interfaces (APIs) to LexisNexis Risk Solutions, switching systems requires years of reprogramming, renewed regulatory certifications, and immense retraining efforts. Lawyers who have built their research routines around LexisNexis also do not switch to alternative providers without good reason, as errors in legal research can have severe liability consequences.
Proprietary, non-replicable data assets: RELX owns historical data assets accumulated over decades and centuries. Comprehensive coverage of global court decisions, copyrighted scientific articles, and billions of historical consumer and identity data points cannot be copied with money alone. Even where primary data is publicly accessible (such as court rulings), the value is created only through RELX’s structured processing, tagging, and linking.
Network effects in the Risk segment: The LexisNexis Digital Identity Network benefits from strong two-sided network effects. The more global banks, e-commerce groups, and insurers feed in their transaction data, the more accurate the fraud-detection algorithms become for all network participants. A new competitor without access to this gigantic data base cannot mathematically offer the same detection accuracy.
Economies of scale in R&D: With a revenue base of nearly £9.6 billion, RELX can invest hundreds of millions annually in developing modern AI architectures. Smaller niche providers cannot keep pace with this investment tempo in model development and data security.
Moat dynamics: Strengthening the moat through generative AI
With the breakthrough of Large Language Models (LLMs), financial markets raised concerns that generic AI models could make the specialist knowledge of data publishers obsolete. On closer inspection, this assumption proves incorrect: RELX’s moat is increasingly widening through generative AI.
Generic AI models are prone to hallucinations—when in doubt, they invent facts or court rulings. In law firms, hospitals, or compliance departments, this is an unacceptable risk. RELX uses its proprietary, verified data assets as a closed foundation for queries via Retrieval-Augmented Generation (RAG). Products such as Lexis+ AI or the AI assistant Protégé access LexisNexis’s verified legal database exclusively. This enables precise, source-backed, hallucination-free answers. Generative AI turns RELX’s unstructured data troves into even more valuable tools, further strengthening customer retention.
Key competitors and peer group comparison
RELX operates in a global oligopoly of specialised data and software providers. Relative market positions are as follows:
| Wettbewerber | Überlappende Segmente | Hauptmarken / Produkte | Marktposition im Vergleich zu RELX |
|---|---|---|---|
| Thomson Reuters | Legal, Tax & Accounting | Westlaw, Practical Law, CoCounsel | Bildet zusammen mit RELX ein faktisches Duopol im US-Rechtsmarkt; RELX wächst im Legal-Bereich dank aggressiverer KI-Integration derzeit hochprofitabel. |
| Wolters Kluwer | Legal, Health, Tax & Compliance | UpToDate, CCH Tagetik | Äußerst hochqualitiver Mitbewerber mit Schwerpunkt Steuer und Gesundheit; RELX besitzt demgegenüber das deutlich größere Risk- und Wissenschaftssegment (Elsevier). |
| Verisk Analytics | Risk (Insurance) | ISO, Argus | Stark auf US-Schadenversicherungen fokussiert; RELX deckt ein breiteres Spektrum an Finanzkriminalitäts- und digitalen Identitätslösungen ab. |
| Experian / Equifax | Risk (Credit & Fraud) | Experian Decision Analytics | Wettbewerber bei Konsumentenkrediten; RELX ist stärker bei komplexen Betrugsmustern, Compliance und Sachversicherungen aufgestellt. |
| Informa PLC | Exhibitions | Informa Markets | Größter direkter Konkurrent bei Fachmessen; RELX (RX) zeichnet sich durch eine höhere Marge und stärkere digitale Datenintegration der Events aus. |
| Competitor | Overlapping Segments | Key Brands / Products | Market Position Relative to RELX |
|---|---|---|---|
| Thomson Reuters | Legal, Tax & Accounting | Westlaw, Practical Law, CoCounsel | Forms a virtual duopoly with RELX in the US legal market; RELX is currently growing highly profitably in the Legal segment thanks to more aggressive AI integration. |
| Wolters Kluwer | Legal, Health, Tax & Compliance | UpToDate, CCH Tagetik | Highly high-quality competitor with a focus on Tax and Health; in contrast, RELX owns significantly larger Risk and Science (Elsevier) segments. |
| Verisk Analytics | Risk (Insurance) | ISO, Argus | Strongly focused on US property and casualty insurance; RELX covers a broader spectrum of financial crime and digital identity solutions. |
| Experian / Equifax | Risk (Credit & Fraud) | Experian Decision Analytics | Competitor in consumer credit; RELX is more strongly positioned in complex fraud patterns, compliance and property insurance. |
| Informa PLC | Exhibitions | Informa Markets | Largest direct competitor in trade exhibitions; RELX (RX) is distinguished by higher margins and stronger digital data integration of events. |
Portfolio uniqueness and niche positioning
RELX does not sell interchangeable mass goods (“commodities”). The company holds absolutely dominant market positions in its core areas. In science, Elsevier is the world’s largest academic publisher with an estimated market share of over 25% of all published peer-reviewed articles. In legal, LexisNexis and Thomson Reuters (Westlaw) control most of the Anglo-American market. In Financial Crime Compliance, LexisNexis Risk Solutions is the undisputed gold standard for major banks.
Pricing power (Pricing Power)
Due to the mission-critical nature of its services, RELX has exceptionally strong pricing power.
First, RELX’s products are non-discretionary for customers. A law firm or a major bank cannot suspend access to LexisNexis or the risk databases to save costs without immediately shutting down operations or violating legal requirements.
Second, RELX is successfully shifting to value-based pricing (Value-Based Pricing). Since new AI tools such as Lexis+ AI demonstrably save lawyers or researchers many working hours, RELX can enforce meaningful price premiums for these AI add-ons. Annual organic price increases reliably exceed the general inflation rate and underscore the outstanding qualitative strength of the RELX stock in the global data and software sector.
Industry analysis, SWOT & governance
Industry structure & macro environment
Market dynamics, growth drivers, and structural trends
The professional information, data, and analytics services industry is in a profound, long-term transformation phase. The global B2B Business Information & Analytics market is growing steadily and is forecast to expand at around 5.0% to 6.5% CAGR, while specialised sub-segments such as Legal Analytics show annual growth rates of over 15.6%. The traditional provision of pure PDF documents, journals, or unstructured legal texts is losing relevance across the industry and is being replaced by highly integrated, software-based decision platforms.
Three overarching structural trends are driving this dynamic in particular:
- Exponential data growth and rising fraud complexity in the Risk segment: Ongoing digitalisation in the global financial sector, e-commerce, and insurance is generating gigantic volumes of data, while simultaneously increasing vulnerability to cybercrime, identity theft, and money laundering. Financial institutions and digital marketplaces are forced to verify transactions in real time to minimise losses and meet regulatory requirements. This requires automated risk assessments based on billions of historical identity and transaction data points, delivering steady volume growth for providers of global data networks such as LexisNexis Risk Solutions.
- Structural efficiency gains in the legal and scientific markets: Law firms, corporate legal departments, and research institutions face ongoing cost pressure. Traditional manual research in case law, contracts, or specialist literature ties up valuable capacity. The industry is therefore shifting from a time-based billing model to AI-supported productivity tools. Platforms capable of performing complex legal analyses or scientific literature syntheses in seconds create invaluable added value and significantly increase corporate customers’ willingness to pay.
- Evolution of scientific publishing (Open Access vs. workflow analytics): In the scientific (STM) segment, there is a shift from pure journal subscriptions to hybrid and open-access (OA) models. While publishing is monetised via author fees (Article Processing Charges, APCs), the primary value driver is increasingly shifting to higher-value analytics tools for research evaluation, grant allocation, and clinical decision support (such as Scopus, SciVal and ClinicalKey AI).
Regulatory environment, geopolitical factors, and technological disruptions
RELX’s operating environment is shaped by a complex web of regulatory requirements and geopolitical tensions, which paradoxically contribute materially to strengthening the market position of established providers:
Regulatory environment & data protection laws: Global privacy frameworks such as the European General Data Protection Regulation (GDPR), the California Consumer Privacy Act (CCPA), and the newly enacted EU AI Act impose extremely high requirements on the handling of personal data and the use of artificial intelligence. While strict privacy rules represent a significant barrier to entry for smaller competitors or AI start-ups, RELX has the financial and legal resources to ensure full compliance of its systems. In addition, corporate clients in legal and financial services require fully auditable, legally robust AI models. Strict AI regulation therefore favours players with closed, copyright-clean data foundations.
Geopolitical dynamics and sanctions regimes: The rise in geopolitical conflicts, tighter trade sanctions (e.g., against Russia or specific technology companies), and internationally coordinated initiatives against tax evasion and money laundering (AML) are leading to a permanent tightening of global compliance requirements. Banks and corporates are under enormous legal pressure to comprehensively screen supply chains and business partners. This regulatory tailwind is driving structurally rising demand for RELX’s real-time compliance databases.
Open-access initiatives in research: Government research funders in Europe (e.g., under Plan S) and the US (OSTP guidelines) are calling for free access to publicly funded research results. This political pressure has put the traditional paywall business model of academic publishers under strain. RELX responded early to this shift: Elsevier has become the world’s largest open-access publisher and offsets lost subscription revenues through APCs and the expansion of profitable medical and scientific software tools.
Technological disruption through generative AI: The emergence of powerful, freely accessible Large Language Models (LLMs) carried the potential risk of commoditising the legal and research industry. However, it has become clear that freely available AI models without specialised data context are unusable in regulated sectors due to their tendency to hallucinate. RELX is actively using this technological shift as an enabler by layering its own generative AI on top of its copyrighted datasets, thereby delivering productivity step-changes for its customers.
SWOT analysis
The following SWOT analysis summarises RELX plc’s internal strengths and weaknesses as well as external opportunities and risks:
Strengths
Data monopolies: Unique, historically grown, non-replicable data monopolies in legal, science, medicine, and digital identity verification.
Excellent financial profile: 34.8% operating margin, 15.4% ROIC, and a highly predictable revenue structure (54% subscriptions, 39% usage-based revenues).
Phenomenal cash flow generation: 99% cash conversion and over £2.3 billion FCF.
High pricing power: Exceptional pricing power through deep embedding in customers’ mission-critical B2B workflows (high switching costs).
AI pioneer role: Technology leadership in the commercial integration of generative AI (e.g., Lexis+ AI, Protégé, ClinicalKey AI).
Weaknesses
Geographic concentration: Revenue concentration in North America (58% of total revenue), creating a degree of dependence on US legal, insurance, and financial markets.
Reputational risk at Elsevier: Ongoing reputational risks in the STM segment regarding pricing and Elsevier’s historical margin versus academic institutions.
Exposure to cyclicality: Remaining operating exposure to cyclical markets in the Exhibitions segment (12% revenue contribution) as well as a declining print business (4%).
Opportunities
Value-Based Pricing: Pricing opportunities from enforcing “value-based pricing” for novel AI workflow tools, enabling higher organic revenue growth.
Fraud prevention boom: Exponential rise in global demand for fraud prevention and anti-money laundering solutions amid booming e-commerce and the FinTech sector.
Regulatory complexity: Rising regulatory complexity worldwide (EU AI Act, ESG reporting, sanctions), pushing customers further towards professional data platforms.
Targeted M&A: Targeted portfolio expansion through disciplined M&A (Bolt-on Acquisitions) in high-growth niches such as aviation, healthcare, or cyber data.
Threats
Tightening open access: Radical regulatory tightening of open-access mandates that could erode the classic subscription model in the STM segment faster than expected.
Open-source AI: Rapid advancement of open-source LLMs or new Big Tech solutions that could reduce willingness to pay for standard research tasks.
Data privacy restrictions: Strict constraints from global data protection laws on using third-party data for fraud detection and consumer profiling.
Macroeconomic shocks: Macroeconomic shocks or geopolitical crises that strain law firm budgets or impair the running of physical B2B trade shows.
Detailed SWOT discussion
Strengths
RELX has an undisputed market position built on irreplaceable data treasures. The combination of centuries of scientific and legal documentation with billions of daily real-time transaction data points in Risk simply cannot be copied by competitors. The financial profile is unmatched in Europe: an adjusted operating margin of 34.8%, paired with a recurring revenue base of over 90% (subscriptions and contractually fixed transactions) and 99% cash conversion, ensures stable earnings even in severe recessions. Tools deeply integrated into customer software create extremely high switching costs, giving RELX genuine pricing power.
Weaknesses
Although RELX is globally positioned, the lion’s share of revenues (58%) comes from North America. A change in US regulation, judicial reforms, or a shock in the US financial and insurance sector would hit the group disproportionately. In addition, the STM segment (Elsevier) has faced criticism in academic circles for years for generating excessively high margins at the expense of publicly funded research. This regularly leads to protracted price negotiations with university consortia. Finally, despite a strong recovery, the Exhibitions segment retains a degree of cyclicality.
Opportunities
The key growth driver in the coming years is the monetisation of generative AI. By shifting from purely user-based licences to value-oriented pricing (Value-Based Pricing), RELX can enforce materially higher revenues per customer seat. Likewise, the global economic environment—with rapidly rising cases of online fraud and money laundering—offers immense expansion opportunities for LexisNexis Risk Solutions. Extremely high cash generation also gives management the tool to continuously acquire specialised data start-ups and strategically strengthen the ecosystem.
Threats
The primary fundamental risk lies in potentially disruptive regulatory steps in scientific publishing. If governments worldwide were to mandate immediate, free publication of all research results and cap author processing costs, this could weigh on Elsevier’s profitability. In addition, continued progress in open-source AI models could reduce the value of simple research tasks. In the Risk segment, stricter consumer data protection laws (restrictions on scraping or linking individual financial and behavioural data) represent a latent risk.
Management quality and capital allocation
Leadership team and corporate governance
RELX is led by an exceptionally experienced, stable, and highly respected management team in the capital markets. Continuity at the top is one of the key success factors behind the group’s smooth strategic transformation:
Chief Executive Officer (CEO) – Erik Engstrom: Erik Engstrom (Swedish citizen; education at the Royal Institute of Technology Stockholm, the Stockholm School of Economics, and an MBA from Harvard Business School) has led the company as CEO since November 2009. Previously, he served as an Executive Director at Elsevier and held leadership roles at Bantam Doubleday Dell, Random House, and the Boston Consulting Group. Engstrom is regarded as the architect of the modern RELX group. Under his more than 15-year leadership, the company consistently transformed from a convoluted print publisher into a focused, highly profitable AI and data group. Engstrom enjoys the highest level of trust among institutional investors, as he aligns strategic decisions uncompromisingly with long-term FCF per share.
Chief Financial Officer (CFO) – Nick Luff: Nick Luff has been RELX’s CFO since 2014. He has decades of experience in complex large corporates and previously served as CFO at energy group Centrica and at BG Group plc. Luff stands for uncompromising financial discipline, meticulous cost management, and transparent reporting.
Chair of the Board – Paul Walker: Paul Walker serves as independent Chair of the Board. He brings many years of experience leading international technology and software groups (including as long-serving CEO of Sage Group).
The management team comes across as highly competent, factual, and honest. Communication with the capital markets has for years been characterised by understatement, reliability, and high forecast accuracy. The quality of corporate governance is also reflected in external ESG ratings: RELX has held MSCI ESG’s top AAA rating for ten consecutive years, ranks in the top 1% of more than 14,700 companies assessed worldwide by Sustainalytics, and is listed in the S&P Global Sustainability Yearbook. In addition, internal employee satisfaction (eNPS) regularly reaches record highs.
Management incentives and pay alignment
The board’s compensation structure is strictly linked to long-term fundamental value creation for shareholders. Variable pay components (Short-Term & Long-Term Incentives) are based on clearly defined, rigorously verifiable metrics:
- Adjusted EPS growth (Adjusted EPS Growth): Ensures that management steadily increases earnings per share.
- Return on capital (Return on Invested Capital, ROIC): Ensures that reinvestments and M&A transactions are value-accretive above the cost of capital (WACC).
- Underlying revenue growth (Underlying Revenue Growth): Rewards genuine organic growth rather than purely acquired revenues.
- Sustainability & ESG targets: Measurable progress in data security, diversity, and environmental footprints flows directly into board compensation.
Board members are also required to hold substantial minimum stakes in RELX shares (typically a multiple of their annual base salary), resulting in full Alignment between management and shareholders.
Capital allocation: reinvestment, dividends, share buybacks and M&A
Management follows a clearly structured, highly disciplined capital allocation model that systematically creates value for shareholders:
Reinvestment in the core business: RELX continuously reinvests around 5% of annual revenue as capex / R&D into the further development of its software platforms, cloud infrastructure, and AI models. This organic innovation ensures the preservation of its technology lead without burdening the balance sheet.
Disciplined M&A strategy (“bolt-on acquisitions”): RELX does not pursue speculative, high-risk mega-mergers as a matter of principle. Instead, management focuses on targeted, smaller add-on acquisitions (Bolt-on Acquisitions). In fiscal year 2025, a total of five companies were acquired for an aggregate £270 million to add specific datasets or AI capabilities. All acquisitions must meet strict return requirements and are rapidly integrated into the central technology platform.
Reliable and rising dividend: RELX follows a progressive dividend policy. The dividend has been increased continuously for more than two decades. For fiscal year 2025, the payout was raised by +7% to 67.5p per share. The dividend is very well covered by free cash flow (payout ratio around 50–55% of adjusted EPS).
Extensive share buybacks: Excess liquidity not required for organic growth or M&A is returned to shareholders in full via share buybacks. In 2025, RELX repurchased its own shares worth £1.5 billion. For 2026, management announced a further increase of the buyback programme to £2.25 billion. This continuous reduction in shares outstanding reliably drives EPS growth beyond pure profit growth.
Balance sheet strength and leverage policy: Management runs the capital structure very conservatively. Net debt to EBITDA stood at a stable 2.0x at the end of 2025 (from 1.8x in 2024). The target corridor of 2.0x to 2.5x net debt/EBITDA secures excellent investment-grade credit ratings and easy access to debt markets at very favourable interest rates (average effective interest rate on gross debt of just 3.9% in 2025).
Summary: qualitative rating of the company
Synthesis: “Wonderful Company” vs. “Commodity Company”
If one conducts a purely qualitative assessment of the company—independent of the current market valuation and short-term market fluctuations—RELX exemplifies all the criteria of a “wonderful business” (Wonderful Business) in the sense of Warren Buffett.
RELX is fundamentally different from an interchangeable “commodity company”. A commodity company sells products with no differentiation, has no pricing power, suffers from the lowest margins, and is helplessly exposed to cyclical market prices. RELX, by contrast, exhibits the exact opposite characteristics:
An impregnable, widening moat (Wide Economic Moat): Irreplaceable proprietary data assets, paired with deep anchoring in mission-critical B2B workflows and strong network effects in Risk, create extreme switching costs for customers.
Outstanding profitability and capital efficiency: With an adjusted operating margin of 34.8% and a return on capital (ROIC) of 15.4%, RELX consistently generates returns well above its cost of capital.
Predictable, highly recession-resistant cash flows: Thanks to a subscription and transaction share of over 93% of total revenues and 99% cash conversion, the company generates massive free cash flow under all economic conditions.
Genuine pricing power (Pricing Power): The mission-critical nature of the products allows RELX to push through price increases above the general inflation rate and profitably monetise AI innovation via value-based pricing models.
First-class leadership and capital allocation: Management under Erik Engstrom acts as an exemplary steward of shareholder capital. It combines disciplined reinvestment with value-accretive share buybacks and steady dividend increases.
In summary, RELX is among the highest-quality data and software groups in the world. The business model functions as a highly profitable compounding engine (Compounding Machine). A detailed analysis of whether the stock’s current fundamental valuation in the market appropriately reflects this exceptional quality profile—or already includes an excessive valuation premium—is the subject of the following valuation and multiple chapters of this Initial Coverage study.
Cash Flow Dynamics, Working Capital, and Deleveraging
One of the most impressive chapters in PALFINGER’s recent financial history is the spectacular intensification of cash flow generation. During the pandemic and supply chain crises of 2021 to 2022, substantial capital was tied up in working capital. From the end of 2023, management initiated a consistent optimization program for Net Working Capital (NWC).
Through the targeted reduction of finished goods inventories, streamlining of supplies, and optimization of days sales outstanding, operating cash flow increased sharply. This resulted in a free cash flow of EUR 119.5 million in 2024 and an absolute record free cash flow of over EUR 180 million in 2025. The FCF margin expanded from a meager 2.0% in 2023 to an excellent 7.7% in 2025.
This massive cash generation was primarily used for accelerated balance sheet deleveraging (Deleveraging). Within just two years, PALFINGER reduced net financial liabilities by more than EUR 200 million to approximately EUR 425 million by the end of 2025. The debt ratio Net Debt / EBITDA improved from previously critical values above 2.5x to an extremely comfortable 1.58x at the end of 2025 and is heading towards values below 1.0x for 2026/2027. In parallel, the equity ratio rose to a solid foundation of approximately 43.0%.
Financial Analysis, Industry KPIs & Valuation
Historical financial analysis & performance evaluation (2021–2025 & outlook)
RELX’s fundamental financial performance over the 2021 to 2025 period underscores the group’s transformation into a highly scalable, data-driven analytics platform. Despite global macroeconomic challenges, interest-rate hiking cycles, and geopolitical instability, the group delivered steady, reliable growth across all key metrics.
Earnings development & revenue quality
Group revenue increased from £7,244 million in 2021 to £9,590 million in 2025. This corresponds to an absolute revenue increase of +32.4% and a compound annual growth rate (CAGR) of +7.3%. The key driver of this development was steady underlying organic revenue growth (underlying revenue growth), which accelerated from +7% in 2021 to +9% in 2022 and was maintained at the high level of +7% in 2023, 2024, and 2025.
Revenue quality improved further structurally over the same period. The share of electronic formats in total revenues climbed to 84%, while the lower-margin, shrinking print business fell to only around 4%. The share of highly predictable recurring revenues (subscriptions and contractually bound volumetric transactions) has consistently remained above 93%.
Profitability & margin analysis
RELX’s operating profitability showed exemplary momentum over the past five years. Adjusted Operating Profit grew from £2,210 million in 2021 to £3,342 million in 2025. This represents a total increase of +51.2% and a CAGR of +10.9%. As operating profit grew significantly faster than revenue, the adjusted operating margin expanded by a total of 430 basis points over the period, from 30.5% (2021) to 34.8% (2025).
This continuous margin expansion of around 80 to 90 basis points per year is the direct result of management’s strategic objective to consistently keep underlying cost growth below underlying revenue growth (Cost-Growth Discipline). The operational economies of scale of the digital software platforms allow additional data queries and new AI services to be processed with minimal incremental variable costs.
Adjusted earnings per share (Adjusted EPS) developed even more dynamically thanks to the combination of operating profit growth and the steady reduction in the number of outstanding shares through share buybacks: it rose from 87.6p in 2021 to 128.5p in 2025, representing currency-adjusted annual growth of around +10% to +17%.
Financial metrics in historical overview and forecast (2021–2027E)
The following table provides a detailed overview of RELX’s historical financial metrics for the years 2021 to 2025 as well as consensus forecasts for 2026E and 2027E:
| Finanzkennzahl (in Mio. GBP, falls nicht anders angegeben) | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E |
|---|---|---|---|---|---|---|---|
| Umsatz (Reported) | 7.244 | 8.553 | 9.161 | 9.434 | 9.590 | 10.180 | 10.850 |
| Unterliegendes Umsatzwachstum (%) | +7 % | +9 % | +8 % | +7 % | +7 % | +7,0 % | +6,8 % |
| EBITDA (Bereinigt) | 2.697 | 3.174 | 3.544 | 3.724 | 3.846 | 4.120 | 4.410 |
| EBITDA-Marge (%) | 37,2 % | 37,1 % | 38,7 % | 39,5 % | 40,1 % | 40,5 % | 40,6 % |
| Operativer Gewinn / EBIT (Bereinigt) | 2.210 | 2.683 | 3.030 | 3.199 | 3.342 | 3.615 | 3.890 |
| Bereinigte Operative Marge (%) | 30,5 % | 31,4 % | 33,1 % | 33,9 % | 34,8 % | 35,5 % | 35,9 % |
| Operativer Gewinn (Reported IFRS) | 1.884 | 2.323 | 2.682 | 2.861 | 3.027 | 3.310 | 3.580 |
| Nettoergebnis (Reported) | 1.471 | 1.634 | 1.785 | 1.934 | 2.065 | 2.280 | 2.490 |
| Bereinigtes Nettoergebnis | 1.710 | 2.001 | 2.235 | 2.241 | 2.358 | 2.560 | 2.780 |
| Bereinigtes EPS (in Pence) | 87,6p | 102,2p | 114,0p | 120,1p | 128,5p | 138,5p | 149,2p |
| Reported EPS (in Pence) | 76,3p | 85,2p | 94,1p | 103,6p | 112,6p | 123,4p | 133,6p |
| Dividende je Aktie (in Pence) | 49,8p | 54,6p | 58,8p | 63,0p | 67,5p | 72,3p | 77,5p |
| Freier Cashflow (FCF, Mio. GBP) | 1.780 | 1.960 | 2.015 | 2.126 | 2.313 | 2.520 | 2.740 |
| Adjusted Cash Flow Conversion (%) | 98 % | 96 % | 97 % | 97 % | 99 % | 98 % | 98 % |
| Kapitalrendite (ROIC, %) | 13,1 % | 13,8 % | 14,0 % | 14,8 % | 15,4 % | 16,1 % | 16,7 % |
| Eigenkapitalrendite (ROE, %) | >100 % | >100 % | >100 % | 181,2 % | 165,0 % | 150,0 % | 140,0 % |
| Gesamtkapitalrendite (ROA, %) | 10,2 % | 11,5 % | 12,1 % | 12,8 % | 13,5 % | 14,2 % | 14,8 % |
| Nettoverschuldung (Net Debt, Mio. GBP) | 6.010 | 6.580 | 6.420 | 6.563 | 7.201 | 7.850 | 8.100 |
| Net Debt / EBITDA | 2,2x | 2,1x | 2,0x | 1,8x | 2,0x | 1,9x | 1,8x |
| Financial Metric (in GBP million, unless stated otherwise) | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E |
|---|---|---|---|---|---|---|---|
| Revenue (Reported) | 7,244 | 8,553 | 9,161 | 9,434 | 9,590 | 10,180 | 10,850 |
| Underlying Revenue Growth (%) | +7% | +9% | +8% | +7% | +7% | +7.0% | +6.8% |
| EBITDA (Adjusted) | 2,697 | 3,174 | 3,544 | 3,724 | 3,846 | 4,120 | 4,410 |
| EBITDA Margin (%) | 37.2% | 37.1% | 38.7% | 39.5% | 40.1% | 40.5% | 40.6% |
| Operating Profit / EBIT (Adjusted) | 2,210 | 2,683 | 3,030 | 3,199 | 3,342 | 3,615 | 3,890 |
| Adjusted Operating Margin (%) | 30.5% | 31.4% | 33.1% | 33.9% | 34.8% | 35.5% | 35.9% |
| Operating Profit (Reported IFRS) | 1,884 | 2,323 | 2,682 | 2,861 | 3,027 | 3,310 | 3,580 |
| Consolidated Net Profit (Reported) | 1,471 | 1,634 | 1,785 | 1,934 | 2,065 | 2,280 | 2,490 |
| Adjusted Net Profit | 1,710 | 2,001 | 2,235 | 2,241 | 2,358 | 2,560 | 2,780 |
| Adjusted EPS (in Pence) | 87.6p | 102.2p | 114.0p | 120.1p | 128.5p | 138.5p | 149.2p |
| Reported EPS (in Pence) | 76.3p | 85.2p | 94.1p | 103.6p | 112.6p | 123.4p | 133.6p |
| Dividend per Share (in Pence) | 49.8p | 54.6p | 58.8p | 63.0p | 67.5p | 72.3p | 77.5p |
| Free Cash Flow (FCF, GBP million) | 1,780 | 1,960 | 2,015 | 2,126 | 2,313 | 2,520 | 2,740 |
| Adjusted Cash Flow Conversion (%) | 98% | 96% | 97% | 97% | 99% | 98% | 98% |
| Return on Invested Capital (ROIC, %) | 13.1% | 13.8% | 14.0% | 14.8% | 15.4% | 16.1% | 16.7% |
| Return on Equity (ROE, %) | >100% | >100% | >100% | 181.2% | 165.0% | 150.0% | 140.0% |
| Return on Assets (ROA, %) | 10.2% | 11.5% | 12.1% | 12.8% | 13.5% | 14.2% | 14.8% |
| Net Debt (GBP million) | 6,010 | 6,580 | 6,420 | 6,563 | 7,201 | 7,850 | 8,100 |
| Net Debt / EBITDA | 2.2x | 2.1x | 2.0x | 1.8x | 2.0x | 1.9x | 1.8x |
Cash Flow Generation & Return on Invested Capital (ROIC / ROE / ROA)
One of the most remarkable characteristics of RELX’s financials is its excellent cash conversion. In 2025, the Group converted 99% of its adjusted operating profit directly into operating cash flow (after 97% in 2024). Free cash flow (Free Cash Flow) increased from £1,780 million (2021) to £2,313 million in 2025.
Return on invested capital (Return on Invested Capital, ROIC) improved steadily from 13.1% in 2021 to 15.4% in fiscal year 2025. This increase demonstrates that management is able to deploy additional capital—whether for organic R&D projects or targeted M&A acquisitions—at returns well above the weighted average cost of capital (WACC of approximately 7.0% to 7.5%).
The return on equity (Return on Equity, ROE) reported under IFRS is at arithmetically extremely high levels of over 160% to 181%. This extremely high value is an accounting peculiarity attributable to the long-standing, extensive share buybacks as well as the offsetting of goodwill from historical acquisitions against equity, which keeps the balance sheet equity base artificially low. Economically more meaningful is therefore the return on assets (Return on Assets, ROA), which rose continuously from 10.2% (2021) to 13.5% (2025).
Balance Sheet Quality, Capital Structure & Working Capital Management
Leverage and Interest Rate Risk
RELX’s balance sheet structure is characterized by high stability and a conservative debt profile. As of 31 December 2025, net debt (Net Debt) amounted to £7,201 million (after £6,563 million in the prior year). The increase in net debt resulted primarily from the execution of the accelerated share buyback program of £1.5 billion as well as acquisition expenditures of £270 million.
In relation to adjusted EBITDA, the leverage ratio (Net Debt / EBITDA) stood at a healthy 2.0x at the end of 2025 (after 1.8x at the end of 2024). This value is exactly at the lower end of management’s target corridor of 2.0x to 2.5x Net Debt/EBITDA.
In the first half of 2026, net debt rose temporarily to £8,733 million due to the rapidly executed £2.25 billion buyback program, corresponding to a Net Debt/EBITDA ratio of 2.3x. Thanks to the customarily strong cash flow generation in the second half of the year, the leverage ratio is expected to decline again towards 1.9x by year-end 2026.
| Bilanzielle Verschuldungskennzahl | 2023 | 2024 | 2025 | H1 2026 |
|---|---|---|---|---|
| Nettoverschuldung (Mio. GBP) | 6.420 | 6.563 | 7.201 | 8.733 |
| Net Debt / EBITDA | 2,0x | 1,8x | 2,0x | 2,3x |
| Durchschnittlicher Effektivzins auf Bruttoschulden | 4,4 % | 4,4 % | 3,9 % | 3,6 % |
| Bereinigter Nettozinsaufwand (Mio. GBP) | 314 | 296 | 283 | 138 |
| Zinsdeckungsgrad (EBITDA / Net Zinsen) | 11,3x | 12,6x | 13,6x | 14,4x |
| Balance Sheet Leverage Metric | 2023 | 2024 | 2025 | H1 2026 |
|---|---|---|---|---|
| Net Debt (GBP million) | 6,420 | 6,563 | 7,201 | 8,733 |
| Net Debt / EBITDA | 2.0x | 1.8x | 2.0x | 2.3x |
| Average Effective Interest Rate on Gross Debt | 4.4% | 4.4% | 3.9% | 3.6% |
| Adjusted Net Interest Expense (GBP million) | 314 | 296 | 283 | 138 |
| Interest Coverage Ratio (EBITDA / Net Interest) | 11.3x | 12.6x | 13.6x | 14.4x |
Interest rate risk is excellently hedged. Despite the global rise in interest rates, the average effective interest rate on RELX’s gross debt declined from 4.4% in 2024 to 3.9% in 2025 and further to 3.6% in the first half of 2026. The adjusted interest coverage ratio (EBITDA / Net Interest Expense) thereby improved from 11.3x in 2023 to an excellent 13.6x in 2025, securing the Group first-class credit ratings of A3 (Moody’s) and A- (S&P).
Working Capital Management
RELX’s working capital management benefits structurally from the characteristics of the subscription model. Since customers in the STM (Elsevier) and Legal (LexisNexis) segments pay their annual subscriptions in advance, RELX has substantial negative net working capital (Negative Net Working Capital). Customers thus effectively pre-finance the ongoing business. Deferred revenue items for advance payments received (Unearned / Deferred Revenue) represent an interest-free, highly stable source of financing and guarantee risk-free liquidity planning.
Multiples & Relative Valuation (Peer Group Comparison)
To assess the valuation of the RELX share, the global peer group of leading information, data, and analytics service providers should be consulted. Direct competitors include Thomson Reuters (Legal & Tax), Wolters Kluwer (Legal, Tax & Health), Verisk Analytics (Insurance & Risk Analytics), Experian (Credit & Fraud Analytics), Equifax, and Informa PLC (Exhibitions).
Peer Group Valuation Table
| Unternehmensname | Ticker / Börse | Marktkapitalisierung (Mio. GBP) | KGV / PE (2025) | KGV / PE (2026E) | EV / EBITDA (2025) | EV / EBIT (2025) | KBV / P/B (2025) | Dividendenrendite 2025 (%) | FCF Yield 2025 (%) |
|---|---|---|---|---|---|---|---|---|---|
| RELX plc | REL LN (LSE) | 74.000 | 21,4x | 19,8x | 13,5x | 17,5x | 20,1x | 2,6 % | 3,8 % |
| Thomson Reuters | TRI TSX (TSX) | 52.500 | 28,4x | 26,6x | 15,5x | 20,5x | 3,5x | 1,8 % | 2,9 % |
| Wolters Kluwer | WKL NA (AEX) | 33.200 | 29,3x | 25,0x | 15,3x | 18,8x | 8,5x | 1,7 % | 3,5 % |
| Verisk Analytics | VRSK US (NASDAQ) | 32.800 | 28,3x | 25,5x | 16,5x | 21,0x | 12,0x | 0,7 % | 3,2 % |
| Experian PLC | EXPN LN (LSE) | 33.500 | 24,1x | 21,5x | 13,6x | 17,2x | 7,2x | 1,6 % | 3,9 % |
| Equifax Inc. | EFX US (NYSE) | 22.100 | 33,6x | 27,2x | 13,5x | 18,2x | 4,8x | 0,8 % | 2,7 % |
| Informa PLC | INF LN (LSE) | 11.200 | 18,5x | 16,2x | 11,5x | 14,2x | 1,8x | 2,2 % | 5,2 % |
| Peer-Group-Median | – | – | 28,3x | 25,0x | 14,4x | 18,2x | 6,0x | 1,7 % | 3,5 % |
| Company Name | Ticker / Exchange | Market Capitalisation (GBP million) | P/E (2025) | P/E (2026E) | EV / EBITDA (2025) | EV / EBIT (2025) | P/B (2025) | Dividend Yield 2025 (%) | FCF Yield 2025 (%) |
|---|---|---|---|---|---|---|---|---|---|
| RELX plc | REL LN (LSE) | 74,000 | 21.4x | 19.8x | 13.5x | 17.5x | 20.1x | 2.6% | 3.8% |
| Thomson Reuters | TRI TSX (TSX) | 52,500 | 28.4x | 26.6x | 15.5x | 20.5x | 3.5x | 1.8% | 2.9% |
| Wolters Kluwer | WKL NA (AEX) | 33,200 | 29.3x | 25.0x | 15.3x | 18.8x | 8.5x | 1.7% | 3.5% |
| Verisk Analytics | VRSK US (NASDAQ) | 32,800 | 28.3x | 25.5x | 16.5x | 21.0x | 12.0x | 0.7% | 3.2% |
| Experian PLC | EXPN LN (LSE) | 33,500 | 24.1x | 21.5x | 13.6x | 17.2x | 7.2x | 1.6% | 3.9% |
| Equifax Inc. | EFX US (NYSE) | 22,100 | 33.6x | 27.2x | 13.5x | 18.2x | 4.8x | 0.8% | 2.7% |
| Informa PLC | INF LN (LSE) | 11,200 | 18.5x | 16.2x | 11.5x | 14.2x | 1.8x | 2.2% | 5.2% |
| Peer Group Median | – | – | 28.3x | 25.0x | 14.4x | 18.2x | 6.0x | 1.7% | 3.5% |
Interpretation of Multiples & Historical Valuation Range
A look at the relative valuation multiples shows that RELX is trading at an attractive valuation discount compared to the global peer group, even though its qualitative fundamentals (ROIC, cash conversion, AI monetization) rank among the best in the industry:
- Price-to-Earnings Ratio (P/E): With a trailing P/E of 21.4x and an estimated forward P/E (2026E) of 19.8x, RELX trades noticeably below its US and European main competitors Thomson Reuters (28.4x FY25), Wolters Kluwer (29.3x FY25), and Verisk Analytics (28.3x FY25). The peer group median stands at 28.3x for 2025.
- Enterprise Value to EBITDA (EV/EBITDA): On an EV/EBITDA basis, RELX at 13.5x for 2025 also trades below the peer group average of 14.4x to 15.5x. Even in historical comparison of its own valuation ranges (3-year average EV/EBITDA at approximately 15.5x to 17.0x), the stock currently shows a moderate valuation premium, leaving room for a multiple re-rating.
- Dividend and FCF Yield: With a dividend yield of around 2.6% and an FCF yield of 3.8%, RELX offers a superior current yield compared to Thomson Reuters (1.8%) and Wolters Kluwer (1.7%) while also having more robust FCF coverage.
Stock drivers & newsflow over the last 12 months
The share price performance of RELX’s ordinary shares on the London Stock Exchange (LSE: REL) showed movement within a 52-week range of 1,991p to 3,575p over the past 12 months. The main volatility spikes and trend reversals in the share price can be precisely attributed to specific fundamental events and macroeconomic currents:
| Zeitraum / Datum | Ereignis / Catalyst | Kursreaktion |
|---|---|---|
| Q4 2024 / Q1 2025 | Generative AI Disruption Scare – Marktsorgen über LLM-Startups & OpenAI. | Kursdruck (-8 % bis -11 %), branchenweiter Abverkauf. |
| 12. Februar 2026 | Veröffentlichung FY 2025 Ergebnisse – Underlying Revenue +7 %, EBIT +9 %, Buyback auf 2,25 Mrd. GBP aufgestockt. | Starke Erholung (+4 % bis +6 %), Beseitigung von KI-Skepsis am Markt. |
| 22. April 2026 | Q1 2026 Trading Update – Reaffirmation des Ganzjahresausblicks über alle 4 Segmente hinweg. | Stabilisierung auf hohem Niveau. |
| 22. Juli 2026 | Veröffentlichung H1 2026 Ergebnisse – Underlying Revenue +7 %, Adj EPS +11 % (CC), Interim Dividend +7 % auf 20,9p. | Kursplus (+3 % bis +5 %), Aktie durchbricht 200-Tage-Durchschnitt nach oben. |
Attribution of Price Movements to Specific Events
- The “AI Disruption Scare” phenomenon (Q4 2024 – early 2025): In the late months of 2024 and early 2025, a wave of sell-offs occurred across the market for legal and scientific data publishers. The reason lay in investor fears that newly released AI workflow tools from Big Tech corporations and emerging LegalTech startups could threaten established research platforms. RELX and Wolters Kluwer shares dropped by up to 11% at times during this phase.
- Fundamental Liberation Through FY2025 Full-Year Results (12 February 2026): The presentation of full-year 2025 figures impressively refuted the disruption thesis. RELX reported underlying revenue growth of +7% to £9,590 million and an increase in operating profit of +9%. The Legal segment stood out particularly with +9% revenue and +12% profit growth, driven by strong adoption of the AI assistant Lexis+ AI. The simultaneous announcement to increase the share buyback program for 2026 to £2.25 billion and raise the dividend by +7% to 67.5p led to a strong price jump and initiated a trend reversal.
- Confirmation of Growth in Q1 2026 Trading Update (22 April 2026): Management confirmed continued strong momentum across all four segments in spring. Investors particularly appreciated the resilience of the Risk segment to changing macroeconomic conditions.
- First Half 2026 Results Trigger Breakout (22 July 2026): The half-year 2026 results provided definitive proof of AI monetization power. An increase in adjusted EPS of +11% (at constant exchange rates) to 68.6p and underlying revenue growth of again +7% exceeded analysts’ expectations. The share subsequently crossed confidently above its 200-day line. The newsflow of the past 12 months impressively demonstrates: Generative AI is not an existential risk for RELX, but the strongest operational share price driver in decades.
Investment Scenarios, Catalysts, Risks & iMaps Conclusion
To make a fundamental decision on the RELX share, a differentiated, multi-layered analysis of both the pronounced opportunity potential and the real risk factors is essential. The following chapter presents the bull and bear perspectives in detail.
Scenario 1: The Bull Perspective – Why RELX Should Be Bought Today
The investment case for an immediate purchase of the RELX share is based on an exceptional combination of operational excellence, structural tailwinds from generative artificial intelligence, and an attractive relative valuation compared to the industry.
1. First-Class Quality and Historical Performance Metrics
Over the past five fiscal years, RELX has impressively demonstrated its role as a reliable compounding machine (Compounding Machine). The Group increased total revenue from £7,244 million (2021) to £9,590 million (2025) and adjusted EBITDA from £2,697 million to £3,846 million. Free cash flow grew in parallel from £1,780 million to £2,313 million. Adjusted earnings per share (Adjusted EPS) rose from 87.6p to 128.5p, representing a double-digit annual growth rate.
At the same time, the development of return on assets (ROA) from 10.2% in 2021 to 13.5% in 2025 as well as the increase in ROIC from 13.1% to 15.4% demonstrates a continuous increase in capital efficiency. The Group generates a return on invested capital that exceeds its weighted cost of capital (WACC of approximately 7.0–7.5%) by more than double.
2. Extent of Valuation Discount Versus Peer Group
Despite this fundamental superiority, the RELX share shows a noticeable valuation discount compared to its direct competitors based on key valuation metrics:
- Price-to-Earnings Ratio (P/E): For fiscal year 2025, RELX trades at a P/E of 21.4x and for 2026E at a forward P/E of 19.8x. This compares to a peer group median of 28.3x (2025) and 25.0x (2026E). US industry leaders such as Thomson Reuters (28.4x FY25) or Verisk Analytics (28.3x FY25) as well as the main European competitor Wolters Kluwer (29.3x FY25) trade at premiums of 30% to 35% versus RELX.
- Enterprise Value to EBITDA (EV/EBITDA): With an EV/EBITDA multiple of 13.5x for 2025, RELX trades significantly below the comparison group average (14.4x to 16.5x).
- Leverage & EV/EBIT: On an EV/EBIT basis, RELX trades at 17.5x (peer median: 18.2x). The leverage metric of Net Debt/EBITDA of 2.0x (2025) also underscores that this valuation discount is by no means caused by elevated balance sheet risk.
3. Notable Developments in Annual Reports & Strategic Restructuring
Anyone analyzing the annual reports of recent years will recognize a remarkable, disciplined evolution of the business model:
- Complete Unification of Corporate Structure (2018): The historical dual holding structure (Reed Elsevier NV in Amsterdam and Reed Elsevier PLC in London) was converted into a transparent, simplified legal entity (RELX PLC). This led to a drastic reduction in administrative and compliance costs as well as an increase in index weighting in the FTSE 100.
- Radical Portfolio Cleanup: The systematic sale of cyclical print magazines, daily newspapers, and unprofitable advertising sheets was consistently executed. Print now contributes only an insignificant 4% to Group revenue.
- Monetization jump through “Value-Based Pricing”: Recent annual reports show a shift in sales focus: instead of selling software licenses at a flat rate based on the number of users (per-seat pricing), RELX is increasingly establishing value-based pricing models (Value-Based Pricing) for AI platforms such as Lexis+ AI and ClinicalKey AI. Since lawyers and doctors save measurable working hours through these tools, customers pay significant price premiums, which flows directly into the operating margin.
4. Potential Catalysts for Multiple Expansion (Re-Rating)
Several operational factors could lead to a revaluation of the share over the next 12 to 24 months:
- Acceleration of Organic Revenue Growth to 8%+: Should market penetration of Lexis+ AI in the Legal segment (revenue growth 2025 already at +9%) and the expansion of fraud detection in the Risk segment permanently lift Group-wide underlying revenue growth from 7% to 8% or more, the market will have to grant RELX a P/E multiple closer to Wolters Kluwer (approximately 25x–28x).
- Massive Share Buybacks as EPS Booster: The announcement to expand the share buyback program in 2026 to £2.25 billion (representing approximately 3% of total share capital) creates artificial demand and reliably drives EPS growth towards 10% to 12% p.a.
- Refutation of the AI Disruption Thesis: Once the broader market definitively realizes that generative AI is not an earnings risk for RELX but a margin accelerator, the market-wide valuation deficit should be rapidly eliminated. These catalysts are only partially priced into the current share price at a P/E of just under 20x for 2026E.
Scenario 2: The Bear Perspective – Why You Should Not Buy the Share Today
Although RELX’s quality profile is undisputed, there are tangible fundamental, regulatory, and valuation-related arguments against a new entry at the current price level.
1. Requirement for Perfection & Market Expectations
The expectations bar for RELX among analysts and institutional investors is extremely high. Market consensus forecasts underlying revenue growth of approximately 6.8% to 7.0% p.a. for 2026E and 2027E, an increase in adjusted EBIT to £3.62 billion and £3.89 billion respectively, and growth in adjusted EPS to 138.5p (2026E) and 149.2p (2027E).
| Kennzahl | FY 2025 (Ist) | FY 2026E (Konsens) | FY 2027E (Konsens) |
|---|---|---|---|
| Umsatz (Mio. GBP) | 9.590 | 10.180 | 10.850 |
| Underlying Growth (%) | +7,0 % | +7,0 % | +6,8 % |
| Bereinigtes EBIT (Mio. GBP) | 3.342 | 3.615 | 3.890 |
| Operative Marge (%) | 34,8 % | 35,5 % | 35,9 % |
| Bereinigtes EPS (Pence) | 128,5p | 138,5p | 149,2p |
| Freier Cashflow (Mio. GBP) | 2.313 | 2.520 | 2.740 |
| Metric | FY 2025 (Actual) | FY 2026E (Consensus) | FY 2027E (Consensus) |
|---|---|---|---|
| Revenue (GBP million) | 9,590 | 10,180 | 10,850 |
| Underlying Growth (%) | +7.0% | +7.0% | +6.8% |
| Adjusted EBIT (GBP million) | 3,342 | 3,615 | 3,890 |
| Operating Margin (%) | 34.8% | 35.5% | 35.9% |
| Adjusted EPS (Pence) | 128.5p | 138.5p | 149.2p |
| Free Cash Flow (GBP million) | 2,313 | 2,520 | 2,740 |
These forecasts leave no room for operational missteps. Should organic growth in one of the core segments (for example, due to budget cuts at US law firms or a slowdown in the insurance business) fall back even slightly to 4% to 5%, the share faces a painful multiple contraction.
2. Absolute Valuation Compared to the Broad Market
While RELX appears visually cheap compared to extremely expensive competitors like Thomson Reuters, the stock is ambitiously valued compared to the overall European and UK markets. With a P/E ratio of 21.4x, RELX has a significant valuation premium over the FTSE 100 Index (average P/E approx. 12x to 14x) and the STOXX Europe 600 (approx. 14x). Investors are paying a high “quality premium.” Should global interest rates remain at elevated levels for longer, growth stocks with high valuation metrics could come under pressure as discount factors for future cash flows rise.
3. Regulatory Risks in the Scientific Segment (STM / Elsevier)
The Scientific, Technical & Medical segment (Elsevier) contributes £2.71 billion in revenue and £1.04 billion in EBIT, representing more than 30% of Group profit, and has an operating margin of an outstanding 38.1%. However, this segment is under permanent political and regulatory fire:
- Tightening of Open Access Mandates: Government funding organizations in the US (OSTP/White House Policy) and Europe (Plan S) require that all research results financed with taxpayer money must be freely accessible to the public immediately upon publication.
- Pressure on Author Processing Costs (APCs): While Elsevier attempts to offset the loss of journal subscriptions through publication fees (Article Processing Charges, APCs), massive resistance is building at universities against fee-based article submission. Should legislators cap publication margins or universities cancel closed consortium agreements, Elsevier faces a structural slowdown in profit growth.
4. Technological Disruption & Open-Source Competition
Even though the bulls’ arguments regarding the hallucination-free nature of Lexis+ AI are valid, the risk from open-source LLMs must not be neglected. Powerful, license-free AI models (such as Meta’s Llama or new specialized LegalTech SaaS providers) are evolving at breakneck speed. Large law firms and corporations could in the medium term build their own internal AI agents based on their own document archives, reducing willingness to pay for expensive external licenses from LexisNexis.
5. Data Privacy and Interest Rate Risk in the Risk Segment
In the Risk segment, RELX analyzes confidential consumer, financial, and transaction data. New, stricter data protection laws (such as the expansion of CCPA in the US or new EU directives regulating digital identity networks) could complicate or prohibit the scraping and linking of third-party data. Additionally, net debt rose temporarily in the first half of 2026 to £8.73 billion or 2.3x Net Debt/EBITDA due to the massive share buyback program. In a scenario of persistently high refinancing rates, this debt level could increase the interest burden and narrow the scope for future dividend increases.
iMaps Conclusion
The iMaps Conclusion provides a clear, fact-based assessment of the RELX share. In our rating, we apply the required strict distribution grid for a universe of listed companies (5% Strong Overweight, 15% Overweight, 60% Neutral, 20% Underweight).
| Kriterium | Bewertung | Fundamentale Begründung |
|---|---|---|
| Geschäftsmodell-Qualität | Exzellent | 34,8 % Marge, 99 % Cash Conversion, planbare wiederkehrende Erlöse (>93 %). |
| Wettbewerbsgraben (Moat) | Breit & Tief | Propriitäre Daten, hohe Wechselkosten, KI als Burggraben-Verstärker. |
| Bilanz & Kapitalallokation | Sehr Stark | 2,0x Net Debt/EBITDA, ROIC von 15,4 %, 2,25 Mrd. GBP Buyback. |
| Relativ-Bewertung | Attraktiv | KGV 21,4x (FY25) vs. Peer-Median 28,3x (30 % Abschlag zu Wolters Kluwer/TRI). |
| Erwartungshaltung | Hoch | Markt verlangt makellose Exekution bei ~7 % organischem Wachstum. |
| Empfehlung | ÜBERGEWICHTEN (OVERWEIGHT) | – |
| Prozentrang-Kategorie | Top 15 % aller analysierten Aktien | – |
| Criterion | Rating | Fundamental Rationale |
|---|---|---|
| Business Model Quality | Excellent | 34.8% margin, 99% cash conversion, predictable recurring revenues (>93%). |
| Economic Moat | Wide & Deep | Proprietary data, high switching costs, AI as a moat amplifier. |
| Balance Sheet & Capital Allocation | Very Strong | 2.0x Net Debt/EBITDA, ROIC of 15.4%, 2.25 bn GBP buyback. |
| Relative Valuation | Attractive | P/E 21.4x (FY25) vs. peer median 28.3x (30% discount to Wolters Kluwer/TRI). |
| Expectations | High | Market demands flawless execution at ~7% organic growth. |
| Recommendation | OVERWEIGHT | – |
| Percentile Category | Top 15% of all analyzed stocks | – |
Specific Recommendation and Rationale
Taking into account all the facts elaborated in the four chapters of this initial coverage study, we rate the shares of RELX plc at the current price level as OVERWEIGHT. Within the prescribed distribution system, we thus classify RELX in the top 15% of the most attractive stocks in the global equity universe.
The rationale for this rating is based on the following key points:
- Exceptional quality of the business model: RELX meets all the criteria of a true “wonderful business” in the sense of Warren Buffett. An operating margin of 34.8%, a free cash flow conversion of 99%, and a ROIC of 15.4% represent the absolute top tier of the European and global software and data sectors.
- AI as Growth Catalyst Rather Than Disruption Object: Management has shown that generative AI does not threaten the existing business model but has permanently accelerated organic revenue growth from historical 3–4% to 7%. The monetization of AI assistants via value-based pricing opens up sustainable pricing power.
- Attractive Relative Undervaluation: While comparable quality monopolies such as Wolters Kluwer, Thomson Reuters, or Verisk Analytics trade at P/E multiples of 28x to 29x, RELX at a P/E of 21.4x for 2025 and 19.8x for 2026E is attractively valued both historically and relatively. The market currently grants the share an unjustified valuation deficit, offering room for significant re-rating by the market.
- Outstanding Shareholder Returns: Management acts as an exemplary steward of capital. The combination of a dividend yield of 2.6% (with annual +7% increases) and a gigantic share buyback program of £2.25 billion for 2026 guarantees continuous value generation for investors, largely independent of the macro environment.
Why is it not quite enough for the “Strong Overweight” category (top 5%)? For the absolute highest rating (“Strong Overweight”), the market’s high expectations for continued flawless organic growth, as well as latent political and regulatory risks in the scientific segment (Elsevier / Open Access), prevent the final push.
Nevertheless, the risk-reward ratio for the long-term oriented investor is exceptionally favorable. RELX belongs in every quality-oriented core portfolio and is a clear buy candidate with the rating OVERWEIGHT.
